Dongwha Pharm.Co.,Ltd
000020.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$148.57B
Close$
Share Statistics
| Market cap | $148.57 Billion |
|---|---|
| Enterprise Value | $251.76 Billion |
| Dividend Yield | $245.00 (4.57%) |
| Earnings per Share | $313.37 |
| Beta | 0.36 |
| Outstanding Shares | 27,718,000 |
Return
| Return on Equity | 4.58% |
|---|---|
| Return on Assets | 2.77% |
| Return on Invested Capital | 4.11% |
Valuation & Multiples
| P/E Ratio | 8.21 |
|---|---|
| PEG | -99.87 |
| Price to Sales | 0.3 |
| Price to Book Ratio | 0.37 |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | 13.3 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 0.32 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$68.60 B
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$68.60 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Dongwha Pharm.Co.,Ltd
815 employees
CEO: Jun-Ha Yoo Dongwha Pharm Co., Ltd. is a South Korean entity primarily engaged in the production and distribution of pharmaceutical goods. The company's diverse offerings include prescription-only medications addressing a wide spectrum of health con...